Spike S1 (D614G)

Spike-S1-Fc (D614G)

fc-sars2-s1g 50 µg Ask for price

Human IgG antibody Laboratories manufactures the spike s1 (d614g) reagents distributed by Genprice. The Spike S1 (D614G) reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S1. Other Spike products are available in stock. Specificity: Spike Category: S1 Group: (D614G)

human anti-human TSHR IgG(S1)

50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

SARS-CoV-2 (COVID-19) S1 protein (D614G), His Tag

100ug
EUR 3017.4
Description: SARS-CoV-2 S1 protein (D614G), His Tag (S1N-C5256) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Arg 685 (Accession # QHD43416.1 (D614G)).

Recombinant SARS-CoV-2 Spike S1(T20N, D614G)(His Tag)

100ug
EUR 1105
Description: SARS-CoV-2

Recombinant SARS-CoV-2 Spike S1(D614G)(His Tag)(Active)

500ug
EUR 2280
Description: SARS-CoV-2

Recombinant SARS-CoV-2 Spike S1(D614G)(His Tag)(Active)

50ug
EUR 290
Description: SARS-CoV-2

Recombinant SARS-CoV-2 Spike S1(D614G),ECD(Fc Tag)

100ug
EUR 1105
Description: SARS-CoV-2

Recombinant SARS-CoV-2 Spike S1(A222V, D614G)(His Tag)

100ug
EUR 1105
Description: SARS-CoV-2

(D614G) information

Recombinant SARS-CoV-2 Spike S1(E154K, L452R, E484Q, D614G, P681R)(His Tag)

PKSV030338-100ug 100ug
EUR 1105
Description: SARS-CoV-2

Recombinant SARS-CoV-2 Spike S1+S2 ECD (ΔHV69-70, D614G, D796H)(His Tag)

PKSV030393-100ug 100ug
EUR 1105
Description: SARS-CoV-2

SARS-CoV-2 (D614G, E484K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)

REC31902-500 0.5
EUR 1885.56
Description: SARS-CoV-2 Spike protein S1 containing both D614G and E484K amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility.

SARS-CoV-2 (D614G, N501Y Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)

REC31930-100 0.1
EUR 496.27
Description: SARS-CoV-2 Spike protein S1 containing both D614G and N501Y amino acid changes relative to the Wuhan-Hu-1 isolate. The N501Y mutation has been reported to increase binding affinity to human ACE2.

SARS-CoV-2 Spike Glycoprotein (D614G Mutation)

abx169319-100l 100 µl
EUR 587.5

SARS-CoV-2 Spike Glycoprotein (D614G Mutation)

abx169319-1ml 1 ml Ask for price

SARS-CoV-2 Spike Glycoprotein (D614G Mutation)

abx169319-200l 200 µl Ask for price

SARS-CoV-2 (D614G, L84I, N439K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)

REC31900-100 0.1
EUR 496.27
Description: SARS-CoV-2 Spike protein S1 containing D614G, L84I and N439K amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility.

SARS-CoV-2 (D614G, L84I, N439K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)

REC31900-500 0.5
EUR 1885.56
Description: SARS-CoV-2 Spike protein S1 containing D614G, L84I and N439K amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility.

GENLISA Human SARS-CoV-2 spike protein S1 mutation D614G Quantitative TITRATION ELISA

KBVH015-35 1 x 96 wells
EUR 660

SARS-CoV-2 Spike S1 Protein (T95I, G142D, E154K, L452R, E484Q, D614G, P681R), His Tag

S1N-C52Ht 100ug
EUR 3017.4
Description: SARS-CoV-2 Spike S1, His Tag (S1N-C52Ht) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Arg 685 (Accession # QHD43416.1). The mutations (T95I, G142D, E154K, L452R, E484Q, D614G, P681R) were identified in the SARS-CoV-2 Kappa variant (Pango lineage: B.1.617.1; other names: 21A/S:154K).

Recombinant SARS-CoV-2 Spike S1(ΔHV69-70, ΔY144, N501Y, A570D, D614G, P681H)(His Tag)

PKSV030347-100ug 100ug
EUR 1105
Description: SARS-CoV-2

Recombinant SARS-CoV-2 Spike S1+S2 ECD (D80A, K417N, E484K, N501Y, D614G, A701V)(His Tag)

PKSV030360-100ug 100ug
EUR 1105
Description: SARS-CoV-2

SARS-CoV-2 Spike Trimer (D614G)-coupled Magnetic Beads

MBS-K016 2mg
EUR 4312.1
Description: SARS-CoV-2 Spike Trimer (D614G) protein is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213(Accession # QHD43416.1 (D614G, R683A, R685A)).

Recombinant SARS-CoV-2 Spike S1 (L18F, D80A, D215G, ΔLAL242-244, R246I, K417N, E484K, N501Y, D614G)(His Tag)

PKSV030363-100ug 100ug
EUR 1105
Description: SARS-CoV-2

Recombinant SARS-CoV-2 Spike S1 (HV69-70/Y144 deletion, N501Y, A570D, D614G, P681H) Protein [His]

DAGC488 100 µg
EUR 1207.5
Description: Recombinant

Spike (SARS-CoV-2, D614G) Pseudotyped Lentivirus (Luc Reporter)

78028-1 100 µl
EUR 900
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein and ACE2 may offer protection against the viral infection. A SARS-CoV-2 variant carrying the spike protein amino acid change D614G has become the most prevalent form in the global pandemic.
The SARS-CoV-2 Spike D614G Pseudotyped Lentivirus were produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1; with D614G mutation) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be measured via luciferase activity. The SARS-CoV-2 Spike D614G pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility._x000D_